** Shares of ReNerve RNV.AX rise 9.5% to A$0.115
** Stock set for its strongest session since March 28, if current trends hold
** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market
** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030
** Stock down 34.3% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。